RecruitingPhase 2

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

NCT06428396

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

City of Hope - Phoenix ( Site 0006)

Goodyear, Arizona, United States

+40 additional locations

Contact

Toll Free Number

1-888-577-8839 Trialsites@msd.com

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2024-11-27
Enrollment: 120 participants
Sponsor: Merck Sharp & Dohme LLC
Purpose: treatment

Locations (41)

City of Hope - Phoenix ( Site 0006)Goodyear, Arizona, United States
Cedars Sinai Medical Center ( Site 0012)Beverly Hills, California, United States
Moores Cancer Center at UC San Diego Health ( Site 0025)La Jolla, California, United States
USC/Norris Comprehensive Cancer Center ( Site 0013)Los Angeles, California, United States
USC Norris Oncology Hematology Newport Beach ( Site 0029)Newport Beach, California, United States
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0011)Marietta, Georgia, United States
Southeastern Regional Medical Center ( Site 0010)Newnan, Georgia, United States
CHRISTUS Highland ( Site 0005)Shreveport, Louisiana, United States
Renown Regional Medical Center ( Site 0018)Reno, Nevada, United States
MD Anderson Cancer Center at Cooper ( Site 0024)Camden, New Jersey, United States
MD Anderson ( Site 0015)Houston, Texas, United States
Mays Cancer Center ( Site 0022)San Antonio, Texas, United States
SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical ( Site 0034)Madison, Wisconsin, United States
Medical College of Wisconsin - Froedtert Hospital ( Site 0014)Milwaukee, Wisconsin, United States
Centro de Investigaciones Metabólicas (CINME)-Oncology ( Site 0504)CABA, Buenos Aires, Argentina
Hospital Británico de Buenos Aires-Oncology ( Site 0500)Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0502)Mar del Plata, Buenos Aires, Argentina
Instituto Alexander Fleming-Alexander Fleming ( Site 0505)Buenos Aires, Buenos Aires F.D., Argentina
Sanatorio Allende - Cerro-Oncology ( Site 0506)Córdoba, Córdoba Province, Argentina
Instituto de Oncología de Rosario ( Site 0501)Rosario, Santa Fe Province, Argentina
Hospital Italiano de Córdoba ( Site 0508)Córdoba, Argentina
Jewish General Hospital ( Site 0400)Montreal, Quebec, Canada
Centro de Investigación del Maule ( Site 4106)Talca, Maule Region, Chile
FALP ( Site 4102)Santiago, Region M. de Santiago, Chile
Pontificia Universidad Catolica de Chile ( Site 4108)Santiago, Region M. de Santiago, Chile
Bradfordhill ( Site 4100)Santiago, Region M. de Santiago, Chile
IMAT S.A.S ( Site 1205)Montería, Departamento de Córdoba, Colombia
Oncologos Del Occidente ( Site 1200)Pereira, Risaralda Department, Colombia
Fundacion Valle del Lili ( Site 1204)Cali, Valle del Cauca Department, Colombia
Seoul National University Hospital ( Site 3100)Seoul, South Korea
Samsung Medical Center ( Site 3101)Seoul, South Korea
National Cheng Kung University Hospital ( Site 3300)Tainan, Taiwan
National Taiwan University Hospital ( Site 3301)Taipei, Taiwan
National Taiwan University Cancer Center ( Site 3302)Taipei, Taiwan
Faculty of Medicine Siriraj Hospital ( Site 3500)Bangkoknoi, Bangkok, Thailand
Faculty of Medicine - Khon Kaen University ( Site 3502)Muang, Changwat Khon Kaen, Thailand
Songklanagarind Hospital ( Site 3501)Hat Yai, Changwat Songkhla, Thailand
The Royal Cornwall Hospital ( Site 1904)Truro, England, United Kingdom
St Bartholomews Hospital ( Site 1900)London, London, City of, United Kingdom
The Christie Hospital NHS Foundation Trust ( Site 1902)Withington, Manchester, United Kingdom
Ipswich Hospital ( Site 1911)Ipswich, Suffolk, United Kingdom